Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1 or 6 Months of Dual Antiplatelet Therapy After Drug-Coated Balloon Angioplasty for De Novo Small Coronary Artery Disease
NCT07592507Phase 4Not yet recruiting
- Sponsor
- Daejeon St. Mary's Hospital
- Start
- May 2026
- Primary completion
- Feb 2032
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, open-label trial of aspirin and clopidogrel in coronary artery disease (CAD) and stable angina pectoris (2 arms), sponsored by Daejeon St. Mary's Hospital. Primary endpoint: Net Adverse Clinical Events at 12 months. Planned start May 2026; status: not yet recruiting.
02
Drugs
aspirinclopidogrel
03
Conditions
coronary artery disease (CAD)stable angina pectoris
Beyond the preview
Go deeper on NCT07592507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07592507.